Genesco Inc. (GCO) Market Cap & Valuation Ratios
Genesco Inc. (GCO) has a market cap of $400.2M, a trailing P/E of 9.3 and a price-to-sales ratio of 0.2, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-08-01 · read by EquiReason
GCOGenesco Inc.Follow GCO — free
—
Price chart with a free account
- Market cap
- 400.2M
- P/E TTM
- 9.3
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Dec, in 39 days
Peers
apparel retail · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| GCO | 0.4 | 9.3 | 0.1 | 3.6 | 18.4% | +3% | 2% | 8% |
| BOOT | 3.5 | 14.6 | 1.4 | 8.3 | 3.3% | +18% | 14% | 21% |
| AEO | 3.0 | 9.1 | 0.5 | 4.3 | 11.4% | +9% | 8% | 20% |
| BKE | 2.4 | 10.7 | 1.6 | 6.9 | 8.0% | +6% | 21% | 104% |
| CRI | 1.2 | 6.1 | 0.4 | 3.3 | 24.5% | +5% | 9% | 23% |
| CAL | 0.4 | — | 0.2 | 4.5 | 14.1% | +7% | 3% | 7% |
| SHOE | 0.4 | 16.1 | 0.2 | 3.8 | 17.3% | -4% | 3% | 4% |
| CTRN | 0.4 | — | 0.4 | 12.6 | 1.7% | +11% | 0.6% | 8% |
| SFIX | 0.3 | — | 0.1 | 181.8 | 5.8% | +6% | -2% | -23% |
| LE | 0.3 | — | 0.2 | 9.8 | — | +0.4% | 0.5% | 0.9% |
| ZUMZ | 0.2 | 20.2 | 0.1 | 3.0 | 11.6% | +4% | 2% | 5% |
| Median of these 10 | 12.7 | 0.3 | 5.7 | 11.4% | +6% | 3% | 7% |
P/E 9.3 vs. a peer median of 12.7; EV/Sales 0.1 vs. 0.3. GCO's own P/E sits at the 74th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesCAL and CTRN and SFIX and LE have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Genesco Inc. — questions
- What is Genesco Inc.'s market cap?
- $400.2M.
- What is Genesco Inc.'s P/E ratio?
- 9.3 on trailing twelve-month earnings to 2026-08-01.
- What is Genesco Inc.'s price-to-sales ratio?
- 0.2.
Every figure on this page comes from Genesco Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.